| Literature DB >> 28890761 |
Ooi Gim Luan1, Hokchai Yam1,2, Razip Samian1, Mustafa Fadzil Farid Wajidi3, Nor Muhammad Mahadi4, Suriani Mohamad5, Nazalan Najimudin1.
Abstract
Burkholderia pseudomallei is a soil-dwelling bacterium that causes a globally emerging disease called melioidosis. Approximately one third of the in silico annotated genes in its genome are classified as hypothetical genes. This group of genes is difficult to be functionally characterised partly due to the absence of noticeable phenotypes under conventional laboratory settings. A bioinformatic survey of hypothetical genes revealed a gene designated as BPSL3393 that putatively encodes a small protein of 11 kDA with a CoA binding domain. BPSL3393 is conserved in all the B. pseudomallei genomes as well as various in other species within the genus Burkholderia. Taking into consideration that CoA plays a ubiquitous metabolic role in all life forms, characterisation of BPSL3393 may uncover a previously over-looked metabolic feature of B. pseudomallei. The gene was deleted from the genome using a double homologous recombination approach yielding a null mutant. The BPSL3393 mutant showed no difference in growth rate with the wild type under rich and minimal growth conditions. An extensive metabolic phenotyping test was performed involving 95 metabolic substrates. The deletion mutant of BPSL3393 was severely impaired in its ethanolamine metabolism. The growth rate of the mutant was attenuated when ethanolamine was used as the sole carbon source. A transcriptional analysis of the ethanolamine metabolism genes showed that they were down-regulated in the BPSL3393 mutant. This seemed to suggest that BPSL3393 functions as a positive regulator for ethanolamine metabolism.Entities:
Keywords: BPSL3393; Burkholderia pseudomallei; ethanolamine
Year: 2017 PMID: 28890761 PMCID: PMC5584837 DOI: 10.21315/tlsr2017.28.2.5
Source DB: PubMed Journal: Trop Life Sci Res ISSN: 1985-3718
Bacterial strains and plasmids.
| Bacterial strains | Genotypes | Source/references |
|---|---|---|
| Tpr Smr
| Biomedal S.L.,Spain. | |
| Wild type strain isolated from a 34 year old female at Khon Kaen Hospital | ( | |
| Derivative of | This study | |
|
| ||
| Plasmids | ||
|
| ||
| RBC TA cloning vector | TA cloning vector, | RBC bioscience, USA |
| pUD-RBC | Derivative of RBC TA cloning vector containing the fused flanking region of gene BPSL3393 | This study |
| pDM4 | Suicidal plasmid, Cmr, | ( |
| pUD3393 | Derivative of pDM4 vector containing the flanking region of gene BPSL3393 | This study |
Primers used in mutant construction. The restriction sites are underlined.
| Primer | Sequence (5′-3′) | Restriction site |
|---|---|---|
| USF | ||
| USR | CCTA | |
| DSF | CCTA | |
| DSR | ||
| USF-EXT | CGGTGATGCTCGGCTATT | - |
| DSR-EXT | CCGGCCGTCCGTTATGATCC | - |
| NQCAT | TAACGGCAAAAGCACCGCCGGACATCA | - |
| NQREV | ACATGTGGAATTGTGAGCGGATAACAA | - |
Primers designed for RT-qPCR study.
| Primers | Sequence (5′-3′) | Genes |
|---|---|---|
| 3368-F | GGCGATGCGTACTGGTT | AraC transcriptional regulator ( |
| 3368-R | GGCGTCAACAGCTCGAA | |
| 3369-F | AGCATCTACGATCGCTTCATC | Acetaldehyde dehydrogenase ( |
| 3369-R | GTCGATGTACGACAGGATCTTC | |
| 3371-F | AGCCTCGGCGTGTATCT | Ethanolamine ammnia-lyase light chain ( |
| 3371-R | GTGCGTCAGCAGGTAGTG | |
| 3372-F | GATCAGGACGACATGGACAA | Ethanolamine ammonia-lyase heavy chain ( |
| 3372-R | GCTCTGGTAGTTCAGCATCA | |
| 3373-F | CGGGATCATTCTCGGCTATTC | Ethanolamine permease ( |
| 3373-R | CGCGATAAGGCGTCTTGAA | |
| dnaK-F | CGCAGATCGAAGTGACCTT | Chaperone protein |
| dnaK-R | ATCTTCTCGATCTCGGCTTC |
Figure 1Markerless deletion of the B. pseudomallei BPSL3393 gene. Gel image of PCR products amplified from wild type strain (lane 1) and ΔBPSL3393 mutant (lane 2). The mutant gave shorter PCR amplicon compared to the wild type strain indicating the deletion of BPSL3393 gene.
Figure 2The growth curve analysis of B. pseudomallei ΔBPSL3393 mutant and wild type strain. (a) both strains have similar growth pattern in LB medium, where both strains reached plateu at approximately 28th hour. (b) B. pseudomallei ΔBPSL3393 mutant strain showed a drastically decrease in OD at 18th hour due to cells aggregation in M9 minimal medium. The error bars represent the values of standard errors.
Figure 3Graph of ethanolamine utilisation rate of B. pseudomallei ΔBPSL3393 mutant and wild type. B. pseudomallei ΔBPSL3393 mutant showed reduced utilisation ability as compared to wild type strain. The error bars represent the values of standard errors.
Figure 4The growth curve analysis of B. pseudomallei ΔBPSL3393 mutant and wild type strain in ethanolamine supplemented media. The growth of B. pseudomallei ΔBPSL3393 mutant showed similar pattern with wild type in ethanolamine minimal medium supplemented with NH4Cl and ethanolamine minimal medium supplemented with glucose. B. pseudomallei showed much better cell growth when the ethanolamine minimal medium was supplemented with carbon source compared to nitrogen source. The error bars represent the values of standard errors.
Figure 5Result of eut genes expression study. The eut genes in the ΔBPSL3393 mutant were down-regulated compared to the wild type strain. The relative fold change values were at least 1.5 for each of the eut genes examined. The error bars represent the values of standard errors.
Figure 6Ethanolamine catabolism (Stojiljkovic ). Ethanolamine is first transported into cell with the help of EutH or diffusion. In the ethanolamine-specific microcompartment, ethanolamine is degraded to acetaldehyde and ammonia by the EutBC with cofactor Ado-B12. Acetaldehyde is either catabolised to ethanol by EutG or to the metabolically useful compound, acetyl-CoA, by EutE. Acetyl-CoA serves as initial subtract for various metabolic processes or converted into acetylphosphate by EutD. EutBC: Ethanolamine ammonia lyase; EutH: Ethanolamine utilization protein H; EutG: Alcohol dehydrogenase; EutE: Acetaldehyde dehydrogenase; EutD: Phosphotransacetylase; NAD: Nicotinamie Adenine Dinucleotide; Pi: Inorganic phosphate; TCA: Tricarboxylic acid cycle; Ado-B12: Adenosylcobalamin.